Work

M402, a heparan sulfate mimetic and novel candidate for the treatment of pancreatic cancer.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.4056

Authors: Birgit Corinna Schultes, Martijn P.J.K. Lolkema, Chia Lin Chu, He Zhou, Alison Long, Michelle Lockley, William Avery, Elma Kurtagic, Zoya Galcheva-Gargova, Paul Miller, Jay Duffner, Birgit J Maschek, Donna Jarlenski, David A. Tuveson, Jim Roach, Ganesh Venkataraman, Takashi K Kishimoto, Keith T. Flaherty

Institutions: Momenta Pharmaceuticals (United States), University Medical Center Utrecht, Queen Mary University of London, Massachusetts General Hospital

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598933489

Cites:

Cited by: 3

Related to: 10